Effect of squalamine on iris neovascularization in monkeys

被引:26
作者
Genaidy, M
Kazi, AA
Peyman, GA
Passos-Machado, E
Farahat, HG
Williams, JI
Holroyd, KJ
Blake, DA
机构
[1] Tulane Univ, Hlth Sci Ctr, Dept Ophthalmol, New Orleans, LA 70112 USA
[2] Genaera Corp, Plymouth Meeting, PA USA
[3] Titan Pharmaceut Inc, San Francisco, CA USA
来源
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES | 2002年 / 22卷 / 06期
关键词
angiogenesis; iris neovascularization; nonhuman primate; squalamine;
D O I
10.1097/00006982-200212000-00014
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To investigate the effect of squalamine, an antiangiogenic aminosterol, in an experimental model of iris neovascularization. Methods: Iris neovascularization was created in cynomolgus monkeys by occluding retinal veins with an argon laser and inducing persistent hypotony with a central corneal suture. Twenty-four eyes were treated in three groups. In Group 1, four eyes were injected intravitreally with 3 mug/0.1 mL squalamine and four eyes with balanced saline solution (controls) immediately after vein occlusion (day 1); injections were repeated every 3 days for 3 weeks. In Group 2, 1 mg/kg squalamine was administered with intravenous infusion in dextrose 5% in four animals; four control animals received only dextrose. Infusions began on day 1 and were repeated every 3 days for 3 weeks. In Group 3, after development of iris neovascularization on day 7, 1 mg/kg squalamine was injected systemically in four animals; four control animals received dextrose 5%. Monkeys were examined by slit-lamp biomicroscopy and underwent color photography and fluorescein angiography. Results: Group 1: All eyes, treated and control, developed intense and persistent rubeosis iridis. Group 2: Two of the four treated eyes in this group developed minimal iris neovascularization; the other two had no iris neovascularization. All four control eyes developed intense, persistent iris neovascularization. Group 3: All eyes developed extensive rubeosis iridis; iris neovascularization regressed in all four treated eyes after squalamine injections. Two of four treated eyes retained minimal iris neovascularization; two showed complete regression of rubeosis iridis. Rubeosis iridis completely regressed in two of the four control eyes; the remaining two control eyes had intense, persistent iris neovascularization. Conclusions: Intravitreally injected squalamine did not affect the development of iris neovascularization; however, systemic squalamine injection inhibited the development of iris neovascularization and caused partial regression of new vessels in a primate model.
引用
收藏
页码:772 / 778
页数:7
相关论文
共 26 条
[1]   Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate [J].
Adamis, AP ;
Shima, DT ;
Tolentino, MJ ;
Gragoudas, ES ;
Ferrara, N ;
Folkman, J ;
DAmore, PA ;
Miller, JW .
ARCHIVES OF OPHTHALMOLOGY, 1996, 114 (01) :66-71
[2]  
Casey R, 1994, PRINCIPLES PRACTICE, P1100
[3]   Exudative macular degeneration and intravitreal triamcinolone: 18 month follow up [J].
Challa, JK ;
Gillies, MC ;
Penfold, PL ;
Gyory, JF ;
Hunyor, ABL ;
Billson, FA .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF OPHTHALMOLOGY, 1998, 26 (04) :277-281
[4]  
FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182
[5]  
Fong DS, 2000, OPHTHALMOLOGY, V107, P2314
[6]  
Gelisken O, 1999, Semin Ophthalmol, V14, P27, DOI 10.3109/08820539909056060
[7]   Target molecules for anti-angiogenic therapy: from basic research to clinical trials [J].
Hagedorn, M ;
Bikfalvi, A .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2000, 34 (02) :89-110
[8]  
HAWKINS BS, 1991, ARCH OPHTHALMOL-CHIC, V109, P1109
[9]  
Higgins RD, 2000, INVEST OPHTH VIS SCI, V41, P1507
[10]   BLINDNESS CAUSED BY DIABETIC-RETINOPATHY [J].
KAHN, HA ;
HILLER, R .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1974, 78 (01) :58-67